Contribution of inflammatory pathways to Fabry disease pathogenesis

Lysosomal storage diseases are usually considered to be pathologies in which the passive deposition of unwanted materials leads to functional changes in lysosomes. Lysosomal deposition of unmetabolized glycolipid substrates stimulates the activation of pathogenic cascades, including immunological pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozenfeld, Paula, Feriozzi, Sandro
Formato: Articulo
Lenguaje:Inglés
Publicado: 2017
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/78691
Aporte de:
id I19-R120-10915-78691
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Bioquímica
Fabry disease
Inflammation
Innate immunity
Enzyme replacement therapy
Lysosome
spellingShingle Bioquímica
Fabry disease
Inflammation
Innate immunity
Enzyme replacement therapy
Lysosome
Rozenfeld, Paula
Feriozzi, Sandro
Contribution of inflammatory pathways to Fabry disease pathogenesis
topic_facet Bioquímica
Fabry disease
Inflammation
Innate immunity
Enzyme replacement therapy
Lysosome
description Lysosomal storage diseases are usually considered to be pathologies in which the passive deposition of unwanted materials leads to functional changes in lysosomes. Lysosomal deposition of unmetabolized glycolipid substrates stimulates the activation of pathogenic cascades, including immunological processes, and particularly the activation of inflammation. In lysosomal storage diseases, the inflammatory response is continuously being activated because the stimulus cannot be eliminated. Consequently, inflammation becomes a chronic process. Lysosomes play a role in many steps of the immune response. Leukocyte perturbation and over-expression of immune molecules have been reported in Fabry disease. Innate immunity is activated by signals originating from dendritic cells via interactions between toll-like receptors and globotriaosylceramide (Gb3) and/or globotriaosylsphingosine (lyso-Gb3). Evidence indicates that these glycolipids can activate toll-like receptors, thus triggering inflammation and fibrosis cascades. In the kidney, Gb3 deposition is associated with the increased release of transforming growth factor beta and with epithelial-to-mesenchymal cell transition, leading to the over-expression of pro-fibrotic molecules and to renal fibrosis. Interstitial fibrosis is also a typical feature of heart involvement in Fabry disease. Endomyocardial biopsies show infiltration of lymphocytes and macrophages, suggesting a role for inflammation in causing tissue damage. Inflammation is present in all tissues and may be associated with other potentially pathologic processes such as apoptosis, impaired autophagy, and increases in pro-oxidative molecules, which could all contribute synergistically to tissue damage. In Fabry disease, the activation of chronic inflammation over time leads to organ damage. Therefore, enzyme replacement therapy must be started early, before this process becomes irreversible.
format Articulo
Articulo
author Rozenfeld, Paula
Feriozzi, Sandro
author_facet Rozenfeld, Paula
Feriozzi, Sandro
author_sort Rozenfeld, Paula
title Contribution of inflammatory pathways to Fabry disease pathogenesis
title_short Contribution of inflammatory pathways to Fabry disease pathogenesis
title_full Contribution of inflammatory pathways to Fabry disease pathogenesis
title_fullStr Contribution of inflammatory pathways to Fabry disease pathogenesis
title_full_unstemmed Contribution of inflammatory pathways to Fabry disease pathogenesis
title_sort contribution of inflammatory pathways to fabry disease pathogenesis
publishDate 2017
url http://sedici.unlp.edu.ar/handle/10915/78691
work_keys_str_mv AT rozenfeldpaula contributionofinflammatorypathwaystofabrydiseasepathogenesis
AT feriozzisandro contributionofinflammatorypathwaystofabrydiseasepathogenesis
bdutipo_str Repositorios
_version_ 1764820486473121794